Simpson Thacher represented the underwriters in the initial public offering and Regulation S offering by Fusen Pharmaceutical Company Limited (“Fusen Pharmaceutical”). Fusen Pharmaceutical offered an aggregate…
Fusen Pharmaceutical’s $53.3 Million Initial Public Offering
